Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
ValiRx News 
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Valirx making progress on several fronts

Life sciences group ValiRx Plc (LON:VAL) is making good progress as it continues to run its lead candidate through the clinical trial process to treat prostate cancer, and  where results so far have..
Proactive Investors

Shares in drug developers Sareum and Valirx soar but oilers endure another bad week

shares in drug developers sareum and valirx soar but oilers endure another bad week
In the last three months the AIM All Share has risen a creditable 15 per cent, outperforming the FTSE 100 (up 9.5 per cent). Sareum's shares have sky-rocketed more than 80 per cent.
MailOnline Also reported by •thisismoney.co.uk

Beaufort Securities Breakfast Alert: Herenica Resources, Keras Resources, Northcote Energy, Stellar Diamonds, ValiRx, BAE Systems, British American Tobacco, BT, Diageo, Domino's Pizza, Merlin Entertainments, Sky

(MENAFN - ProactiveInvestors - UK) Beaufort Securities, 08:32 Markets Europe The FTSE-100 finished yesterday's session 0.44% lower at 6,721.06, whilst the FTSE AIM All-Share ...
MENAFN.com

Risers & fallers: Baron Oil, Blenheim Natural Resources, Bluebird Merchant Ventures, Brave Bison, Harvest Minerals, ValiRx

Below are some of the main news-driven share price changes at 9.15am. RISERS Baron Oil PLC (LON:BOIL), up 19%. The outgoing President of the Republic of Peru has signed the supreme decree with respect..
Proactive Investors

Proactive news highlights: Bacanora, Leni Gas Cuba, Metal Tiger, Westminster Group and more...

Leni Gas Cuba Limited (ISDX:CUBA) announced that shareholders had unanimously approved the previously-announced reverse take-over of Knowlton. Shareholders also approved a change of corporate name to..
Proactive Investors

ValiRx PLC readies for phase II clinical trial of lead cancer drug

ValiRx Plc (LON:VAL) said manufacturing of VAL401 had begun ahead of a phase II clinical trial of the drug in patients with advanced lung cancer. The study will assess efficacy, safety and tolerability..
Proactive Investors

ValiRx joint venture awarded second US patent

Cancer drug developer ValiRx Plc’s (LON:VAL) joint venture Valiseek has received a US patent for its lead compound VAL401 as a possible treatment for adenocarcinoma cancers. The drug is targeting..
Proactive Investors

ValiRx PLC to present at leading US cancer conference

Shares in ValiRx PLC (LON:VAL) rose 2% after the life sciences specialist said it would be presenting research data at a leading oncology get-together in the US next month. The American Association for..
Proactive Investors

Risers and Fallers: Gulfsands PLC, NetPlay TV, ValiRx PLC...

Major share price movers in London at 9.45am RISERS Gulfsands Petroleum PLC (LON;GPX) up 52% to 7.55p.  Further recovery after results on Friday. Syrian operations suspended but company remains..
Proactive Investors

ValiRx PLC targets US institutions with new appointment

ValiRx Plc (LON:VAL) has appointed a specialist investor relations firm to build its recognition among academic, clinical, and business leaders in the US.  Burns McClellan has already carried out an..
Proactive Investors

ValiRx trial group receives cancer treatment with no adverse effects

ValiRx (LON:VAL) said a further group of patients receiving VAL201 have completed the clinical trial dosing sequence with no significant adverse effects. VAL201 is being developed to treat..
Proactive Investors

Small cap highlights: Europa, Providence, Rockhopper, DP Poland, 32 Red, Tern, ValiRX, and more

Europa Oil & Gas (LON:EOG) shot up by about a third in Friday’s early deals as a new licensing round offshore Ireland showed the small cap oiler is punching above its weight. The AIM-quoted explorer..
Proactive Investors

Proactive news summary, including Alliance Pharma, Planet Payment, OPG Power Ventures and Redx Pharma

Plenty of sparks today - Bonfire Night -  on the Proactive site. Alliance Pharma (LON:APH) shares advanced after it said it will receive £6.7mln in compensation after it settled with Sanofi Pasteur..
Proactive Investors

ValiRx sets up in Boston to strengthen investor base

Cancer drug developer ValiRx (LON:VAL) has established a US operation in Cambridge, Massachusetts and beefed up its US advisory team.  The aim is to encourage interaction with academic, clinical and..
Proactive Investors


You Might Like


Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+